A study of the clinical pharmacokinetics of individual drugs and groups of drugs, sources of inter-patient variability in pharmacokinetics and the application of pharmacokinetics in practice. As with Clinical Pharmacokinetics 3, particular emphasis is placed on the role of the pharmacist in improving the use of drugs through the practical application of pharmacokinetics and therapeutic drug monitoring. There is extensive use of clinically-oriented problems and cases.
Topics include therapeutic drug monitoring; drug interactions; an overview of sources of inter-patient variability in pharmacokinetics (eg extremes of age, renal or hepatic disease, pharmacogenomics); clinical case studies and pharmacokinetics of specific drugs.
Unit objective: to develop the ability to contribute to improved drug use through the appropriate use of pharmacokinetic techniques and therapeutic drug monitoring.
|Unit name||Clinical Pharmacokinetics 4|
|College/School||College of Health and Medicine
School of Pharmacy and Pharmacology
|Coordinator||Doctor Barbara Wimmer|
|Available as student elective?||No|
|Delivered By||University of Tasmania|
|Location||Study period||Attendance options||Available to|
- International students
- Domestic students
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
|Study Period||Start date||Census date||WW date||End date|
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see withdrawal dates explained for more information).
Unit census dates currently displaying for 2022 are indicative and subject to change. Finalised census dates for 2022 will be available from the 1st October 2021.
- Apply pharmaceutical science knowledge (including pharmaceutical calculations) and/or pharmacokinetic principles to solve clinical problems that may contribute to improved quality use of medicines.
- Describe / evaluate / resolve drug interactions, and common side effects of major drug classes in the context of pharmacy practice.
- Provide accurate and appropriate health and medicines advice to a range of consumers (including other health professionals)
- Search, evaluate and appropriately reference drug information and pharmacy related literature
|Field of Education||Commencing Student Contribution 1||Grandfathered Student Contribution 1||Approved Pathway Course Student Contribution 2||Domestic Full Fee|
- Available as a Commonwealth Supported Place
- HECS-HELP is available on this unit, depending on your eligibility3
- FEE-HELP is available on this unit, depending on your eligibility4
1 Please refer here more information on student contribution amounts.
2 Information on eligibility and Approved Pathway courses can be found here
3 Please refer here for eligibility for HECS-HELP
4 Please refer here for eligibility for FEE-HELP
Please note: international students should refer to this page to get an indicative course cost.
PrerequisitesCSA311 AND All Year 2 BPharm Units
|Assessment||In-class tests (10%)|Exam (65%)|Visual presentation (10%)|Paired written assignment (15%)|
|Timetable||View the lecture timetable | View the full unit timetable|
Required readings will be listed in the unit outline prior to the start of classes.
|Links||Booktopia textbook finder|
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.